BOSTON SCIENTIFIC CORPORATION INVIVE; PULSE GENERATOR, PACEMAKER, IMPLANTABLE, WITH CARDIAC RESYNCHRONIZATION (CRT-P)
|
Back to Search Results |
|
Model Number V173 |
Device Problems
Signal Artifact/Noise (1036); Over-Sensing (1438); Pacing Problem (1439); Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
Patient Problems
No Code Available (3191); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/26/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy pacemaker (crt-p) had three error messages that revered the device to safety mode.In safety mode, the device paces in unipolar configuration which resulted in noise oversensing and pacing inhibition greater than 3 seconds.This crt-p was ultimately removed and replaced.No additional adverse patient effects were reported.This product has not been returned.This report will be updated, should additional information be received.
|
|
Manufacturer Narrative
|
The patient code 3191 accounts for the surgical intervention that occurred.Upon receipt at our post market quality assurance laboratory, this device was thoroughly inspected and analyzed.Interrogation of the device confirmed it was operating in safety mode and that both brady and tachy therapy remained available.Review of device memory identified an error, which resulted in software resets that were performed in an attempt to correct the error.These resets then caused the device to enter safety mode.The battery was removed and detailed analysis was able to confirm the cell had a high internal impedance.The high internal impedance resulted in the software resets, reversion to safety mode operation and oversensing of noise with pacing inhibition.
|
|
Event Description
|
It was reported that this cardiac resynchronization therapy pacemaker (crt-p) had three error messages that revered the device to safety mode.In safety mode, the device paces in unipolar configuration which resulted in noise oversensing and pacing inhibition greater than 3 seconds.This crt-p was ultimately removed and replaced.No additional adverse patient effects were reported.This product has not been returned.This report will be updated, should additional information be received.The product was received for analysis.
|
|
Search Alerts/Recalls
|
|
|